IndraLab

Statements


| 1

reach
"MARV matrix protein VP40 is also a known IFN antagonist, blocking the JAK1 activation of downstream IFN signaling [14,16], and a putative MARV GP immunomodulatory domain has yet-unknown effects in ERBs [38]."